Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.

Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.

Bibliographic Details
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4164659
id doaj-1bbe1074a96b47a09f0ec9ee0bef038a
record_format Article
spelling doaj-1bbe1074a96b47a09f0ec9ee0bef038a2020-11-24T21:51:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-019910.1371/journal.pone.0108710Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.http://europepmc.org/articles/PMC4164659
collection DOAJ
language English
format Article
sources DOAJ
title Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
spellingShingle Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
PLoS ONE
title_short Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
title_full Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
title_fullStr Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
title_full_unstemmed Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
title_sort correction: dusp1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
url http://europepmc.org/articles/PMC4164659
_version_ 1725880905782788096

Similar Items